Acesso livre
Acesso livre

Oncologia

#ASCO22 – Estudo de braço único fases 1-2 | Teclistamabe no mieloma múltiplo recidivante ou refratário.

13 Jun, 2022 | 14:38h

Teclistamab in Relapsed or Refractory Multiple Myeloma – New England Journal of Medicine

 

Comentário no Twitter

 

#ASCO22 – Estudo randomizado | Terapia tripla, transplante e manutenção até a progressão no mieloma.

13 Jun, 2022 | 14:37h

Triplet Therapy, Transplantation, and Maintenance until Progression in Myeloma – New England Journal of Medicine (link para o resumo – $ para o texto completo)

Comunicado de imprensa: Improved progression-free survival in multiple myeloma patients following three-drug therapy with autologous stem cell transplant – Dana-Farber Cancer Institute

 

Comentário no Twitter

 

Diretriz para síndrome carcinoide e doença cardíaca carcinoide.

13 Jun, 2022 | 14:06h

European Neuroendocrine Tumor Society (ENETS) 2022 Guidance Paper for Carcinoid Syndrome and Carcinoid Heart Disease – Journal of Neuroendocrinology

Diretriz de consenso | Papel atual da imunoterapia nos cânceres gástrico, esofágico e de junção gastroesofágica.

13 Jun, 2022 | 14:05h

Current Role of Immunotherapy in Gastric, Esophageal and Gastro-Esophageal Junction Cancers—A Report from the Western Canadian Gastrointestinal Cancer Consensus Conference – Current Oncology

Comparação prospectiva entre médicos oncologistas e modelo de aprendizado de máquina (machine learning) para predizer a mortalidade em 3 meses de pacientes com tumores sólidos metastáticos.

13 Jun, 2022 | 14:04h

Prospective Comparison of Medical Oncologists and a Machine Learning Model to Predict 3-Month Mortality in Patients With Metastatic Solid Tumors – JAMA Network Open

 

Comentário no Twitter

 

Estudo de coorte nacional | Associação entre terapia de supressão androgênica e doença cardiovascular e mortalidade por todas as causas no câncer de próstata não metastático.

13 Jun, 2022 | 13:57h

Association between medical androgen deprivation therapy and long-term cardiovascular disease and all-cause mortality in nonmetastatic prostate cancer – International Journal of Cancer

Comentário: ADT for Prostate Cancer: What’s the Risk on the Heart? – Medscape (necessário cadastro gratuito)

Resumo das melhores evidências de ERAS (enhanced recovery after surgery) para pacientes submetidos a cirurgias de câncer de pulmão.

13 Jun, 2022 | 13:47h

Summary of best evidence for enhanced recovery after surgery for patients undergoing lung cancer operations – Asia-Pacific Journal of Oncology Nursing

Conteúdos relacionados:

Guidelines for enhanced recovery after lung surgery: recommendations of the Enhanced Recovery After Surgery (ERAS®) Society and the European Society of Thoracic Surgeons (ESTS) – European Journal of Cardio-Thoracic Surgery

Enhanced recovery programs in lung cancer surgery: systematic review and meta-analysis of randomized controlled trials – Cancer Management and Research

Clinical guidelines on perioperative management strategies for enhanced recovery after lung surgery – Translational Lung Cancer Research

Systematic Review and Meta-Analysis of Randomized, Controlled Trials on Preoperative Physical Exercise Interventions in Patients with Non-Small-Cell Lung Cancer – Cancers

Preoperative exercise training for patients with non‐small cell lung cancer – Cochrane Library

Estudo de autópsias: metástases cardíacas de tumores sólidos.

13 Jun, 2022 | 13:44h

Cardiac Metastasis From Solid Cancers: A 35-Year Single-Center Autopsy Study – Archives of Pathology & Laboratory Medicine

Revisão | Integração da biologia genômica nas estratégias terapêuticas para metástase peritoneal de câncer gástrico.

13 Jun, 2022 | 13:43h

Integration of Genomic Biology Into Therapeutic Strategies of Gastric Cancer Peritoneal Metastasis – Journal of Clinical Oncology

Revisão sistemática de diretrizes para profilaxia do tromboembolismo venoso na oncologia ginecológica.

13 Jun, 2022 | 13:41h

A Systematic Review of the Guidelines on Venous Thromboembolism Prophylaxis in Gynecologic Oncology – Cancers

Mantenha-se atualizado em sua especialidade

 

Escolha quantas especialidades quiser.